Catalio Capital Management
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.7B
Focus Areas
4
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| atai Life Sciences | $1.3B |
| Neumora Therapeutics | $426.5M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| atai Life Sciences | $1.3B |
| Neumora Therapeutics | $426.5M |